Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome?
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A number of patients with adrenal incidentaloma are exposed to a slight degree of cortisol excess resulting from functional autonomy of the adrenal mass (usually a cortical adenoma). At present, there are only scant data on the unwanted effects of this endocrine condition referred to as subclinical Cushing's syndrome. The aim of the present study was to look for some features of the metabolic syndrome in patients with incidental adrenal adenoma. Forty-one patients (9 men and 32 women) bearing adrenal incidentaloma with typical computed tomography features of cortical adenoma were studied. For both patients and controls, exclusion criteria were age equal to 70 yr or greater, previous history of fasting hyperglycemia, or impaired glucose tolerance (IGT), severe hypertension, current use of medication or concomitant relevant illnesses, and body mass index (BMI) equal to 30 kg/m(2) or greater. Forty-one patients with euthyroid multinodular goiter accurately matched for sex, age, and BMI served for a 1:1 case-control analysis. The study design included an oral glucose tolerance test (75 g) and an endocrine workup aimed at the study of the hypothalamic-pituitary-adrenal axis. Age and BMI were fully comparable between patients (54.0 +/- 10.7 yr, 23.8 +/- 2.4 kg/m(2)) and controls (52.2 +/- 11.6 yr, 23.5 +/- 2.8 kg/m(2)). Fasting glucose and fasting insulin levels were not different between the two groups (4.96 +/- 0.61 mmol/liter vs. 4.88 +/- 0.58 mmol/liter; 67 +/- 34 pmol/liter vs. 59 +/- 32 pmol/liter), but the 2-h postchallenge glucose was significantly higher in patients than in controls (7.43 +/- 2.49 mmol/liter vs. 6.10 plus minus 1.44 mmol/liter, P = 0.01). Fifteen patients (36%) reached the World Health Organization criteria for IGT and two other patients (5%) reached those for diabetes, and 14% of the controls qualified for IGT (P = 0.01). No difference in the lipid pattern was seen between the two groups, but either systolic or diastolic blood pressure were higher in patients (135.4 +/- 15.5 mm Hg vs. 125.0 +/- 15.6 mm Hg, P = 0.003; 82.9 +/- 9.1 mm Hg vs. 75.3 +/- 6.6 mm Hg, P < 0.0001). We calculated the whole-body insulin sensitivity index derived from the oral glucose tolerance test that was significantly reduced in the patients (4.3 +/- 1.7 vs. 5.7 +/- 2.5, P = 0.01). In a multiple regression analysis, 2-h glucose was associated with BMI and midnight cortisol values (r(2) = 0.36, P = 0.002). The comparison of the patients with nonfunctioning adenoma (n = 29) with those with subclinical Cushing's syndrome (n = 12) yielded significant differences as to 2-h glucose and triglyceride levels, which were significantly higher in the second group (7.02 +/- 1.76 mmol/liter vs. 8.72 +/- 3.17 mmol/liter, P = 0.03; 1.06 +/- 0.4 mmol/liter vs. 1.73 +/- 0.96 mmol/liter, P = 0.002), but the insulin sensitivity index was conversely reduced (5.2 +/- 1.4 vs. 2.9 +/- 1.2, P < 0.0001). In conclusion, many patients with incidental adrenal adenoma display altered glucose tolerance, that may be explained by reduced insulin sensitivity, and increased blood pressure levels in comparison with carefully age- and BMI-matched controls. The slight hypercortisolism observed in some such patients may significantly contribute to this state of insulin resistance. Midnight serum cortisol appears as a sensitive marker of the metabolic effects of subclinical Cushing's syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The -mg dexamethasone overnight suppression test is recommended for screening patients with AI for SCS, setting the threshold at nmol/L; a value of nmol/L virtually excludes SCS, whereas values between and nmol/L occupy an area of uncertainty ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [207]
In the citing paper
“Focusing on glucose metabolism, the prevalence of IGT or DM has been higher in patients with SCS than in cases of nonfunctioning adenoma or controls (, , , , , , ), but these data were not confirmed by other studies that found much the same prevalence of these comorbidities in SCS as in the overall series of AI and in the general population (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [207]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 855
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Diagnosing Insulin Resistance in the General Population
McAuley, K. A., Williams, S. M., Mann, J. I., Walker, R. J., Lewis-Barned, N. J., Temple, L. A., & Duncan, A. W. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.460 · Cited by 752
Cited by
Items 201–300 of 369
Bilateral adrenal incidentaloma with subclinical hypercortisolemia: indications for surgery
Papierska, L., Ćwikła, J. B., Rabijewski, M., Glinicki, P., Otto, M., & Kasperlik-Zaluska, A. A. (2014) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2347 · Cited by 11
Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH
Olsen, H., Olofsson, L., & Mjöman, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12295 · Cited by 11
Comparison of echocardiographic findings in patients with nonfunctioning adrenal incidentalomas
İmga, N. N., Elalmış, Ö. U., Tuna, M. M., Dogan, B. A., Şahin, D., Gursoy, T., Yalçın, Y., Berker, D. S., & Güler, S. (2017) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2017.04.002 · Cited by 11
Harman, E., Karadeniz, M., Biray, C., Zengi, A., Çetinkalp, Ş., Özgen, G., Saygılı, F., Berdeli, A., Gündüz, C., & Yılmaz, C. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345766 · Cited by 11
Han, M., Cao, X., Zhao, C., Yang, L., Yin, N., Shen, P., Zhang, J., Gao, F., Ren, Y., Liang, D., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.544752 · Cited by 10
Cardiovascular risk factors in mild adrenal autonomous cortisol secretion in a Caucasian population
Adamska, A., Ulychnyi, V., Siewko, K., Popławska‐Kita, A., Szelachowska, M., Adamski, M., Buczyńska, A., & Kretowski, A. J. (2022) · Endocrine Connections · doi:10.1530/ec-22-0074 · Cited by 11
Ueland, G. Å., Methlie, P., Heie, A., Stokland, A. M., Dahle, A. L., Sævik, Å. B., Løvås, K., & Husebye, E. S. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad076 · Cited by 10
Lazúrová, I., Spišáková, D., Wagnerová, H., Habalová, V., Dravecká, I., Petrášová, D., Drahovská, I., & Pundová, L. (2011) · Wiener klinische Wochenschrift · doi:10.1007/s00508-011-0064-2 · Cited by 10
Vasilev, V., Matrozova, J., Elenkova, A. P., & Zacharieva, S. (2014) · Open Medicine · doi:10.2478/s11536-013-0199-9 · Cited by 10
Krzyżewska, K., Niemczuk, E., Myśliwiec, B. J., & Junik, R. (2017) · Endokrynologia Polska · doi:10.5603/ep.a2017.0034 · Cited by 10
Tsentidis, C., Bampilis, A., Ntova, V., Fragkos, D., Panos, C., Limniati, C., & Kassi, G. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0754-6464 · Cited by 10
Differential Diagnosis of Cushing’s Syndrome
Javorsky, B. R., Carroll, T. B., & Findling, J. W. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_7 · Cited by 10
Subclinical Cushing's syndrome in adrenal incidentalomas--possible metabolic consequences.
Bohdanowicz-Pawlak, A., Szymczak, J., Waszczuk, E., Bolanowski, M., & Bednarek-Tupikowska, G. (2013) · PubMed · Cited by 10
Bleier, J., Pickovsky, J., Apter, S., Fishman, B., Dotan, Z., Tirosh, A., & Shlomai, G. (2021) · Clinical Endocrinology · doi:10.1111/cen.14651 · Cited by 9
Szychlińska, M., Rzeczkowska, M., Gontarz-Nowak, K., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144612 · Cited by 9
Subclinical Cushing's syndrome
Tsinberg, M., Liu, C., & Duh, Q. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23143 · Cited by 9
Adaptive and maladaptive cortisol responses to pediatric obesity
Soros, A., Zadik, Z., & Chalew, S. A. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.04.020 · Cited by 9
[Diagnostic difficulties in adrenal incidentaloma--analysis of 125 cases].
Myśliwiec, J., Rudy, A., Siewko, K., Myśliwiec, P., Pułka, M., & Górska, M. (2007) · PubMed · Cited by 9
Risk Estimator for Adrenal Tumor Functionality
Sadler, C., & Goldfarb, M. R. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2524-0 · Cited by 9
Tabarin, A., Bardet, S., Bertherat, J. Y., Chabre, O., Dupas, B., Hamoir, E., Laurent, F., Tenenbaum, F., Cazalda, M., Rohmer, V., et al. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.002 · Cited by 9
Ceccato, F., Occhi, G., Albiger, N. M. E., Rizzati, S., Ferasin, S., Trivellin, G., Mantero, F., & Scaroni, C. M. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03347459 · Cited by 9
Update on the Diagnosis of Cushing Syndrome
Liu, H., & Crapo, L. M. (2005) · The Endocrinologist · doi:10.1097/01.ten.0000162374.56442.ea · Cited by 9
Adrenopause – does it really exist?
Papierska, L. (2017) · Menopausal Review · doi:10.5114/pm.2017.68593 · Cited by 8
GH secretion reserve in subclinical hypercortisolism
Palmieri, S., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Cairoli, E., Zhukouskaya, V. V., Beck-Peccoz, P., Scillitani, A., & Chiodini, I. (2013) · Pituitary · doi:10.1007/s11102-013-0528-7 · Cited by 8
Metabolic syndrome and Visceral Adiposity Index in non-functional adrenal adenomas
Karataş, S., Hacıoğlu, Y., & Beysel, S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000547 · Cited by 8
Incidentalomas suprarrenales: experiencia clínica en los hospitales de Castilla-La Mancha
Lamas, C., Palma, M., Martín, D., de Frutos, V. Á., López, M., & Marco, A. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)72708-1 · Cited by 8
Reimondo, G., Allasino, B., Coletta, M., Pia, A. R., Peraga, G., Zaggia, B., Massaglia, C., Paccotti, P., & Terzolo, M. (2015) · International Journal of Endocrinology · doi:10.1155/2015/674734 · Cited by 8
Self-citationAdrenal incidentalomas and subclinical Cushing’s syndrome
Abdelmannan, D. K., & Aron, D. C. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9141-5 · Cited by 8
Ammoury, R., Heptulla, R. A., Tatevian, N., & Elenberg, E. (2005) · Pediatric Nephrology · doi:10.1007/s00467-005-2114-3 · Cited by 8
The metabolic syndrome revisited
Lefèbvre, P. J. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00141-9 · Cited by 8
Intsidentaloma nadpochechnikov
Beltsevich, D. G., Kuznetsov, N. S., Soldatova, T. V., & Vanushko, V. E. (2009) · Endocrine Surgery · doi:10.14341/2306-3513-2009-1-19-23 · Cited by 8
İmga, N. N., Topçuoğlu, C., Berker, D. S., & Turhan, T. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.07.002 · Cited by 8
Ersöz, F., Erbil, Y., Sarı, S., Salmaslıoğlu, A., İşsever, H., Aral, F., & Özarmağan, S. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1012-z · Cited by 8
Enberg, U., Hennings, J., Volpe, C., Hellman, P., Höög, A., Hamberger, B., & Thoren, M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345750 · Cited by 8
Kuzu, İ., Zuhur, S. S., Demir, N., Aktas, G., Öztürk, F. Y., & Altuntaş, Y. (2016) · Endokrynologia Polska · doi:10.5603/ep.a2016.0028 · Cited by 7
Torrecilla, N. B., Cano, A. M. G., Valderrábano, P., Tobar, A. Q., Escobar-Morreale, H. F., & Castro, M. A. (2023) · Endocrine · doi:10.1007/s12020-023-03396-6 · Cited by 7
Obesity-Associated Hypertension
Uwaifo, G. I. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_13 · Cited by 7
Insulin sensitivity in patients with adrenal incidentaloma
Ivović, M., Vujović, S., Penezić, Z., Žarković, M., & Drezgić, M. (2006) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0608315i · Cited by 7
Gianotti, L., Tassone, F., Pia, A. R., Bovio, S., Reimondo, G., Visconti, G., Terzolo, M., & Borretta, G. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9245-7 · Cited by 6
Self-citationBleier, J., Shlomai, G., Fishman, B., Dotan, Z., Rosenzweig, B., & Tirosh, A. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0111 · Cited by 6
Szychlińska, M., Rzeczkowska, M., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2023) · Endokrynologia Polska · doi:10.5603/ep.95139 · Cited by 6
Nishikawa, T., Saito, J., & Omura, M. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00207-x · Cited by 6
Differential diagnostics of adrenal incedentaloma
Kuznetsov, N. S., Beltsevich, D. G., Vanushko, V. E., Soldatova, T. V., Ремизов, О. В., Kats, L. E., & Lysenko, M. A. (2011) · Endocrine Surgery · doi:10.14341/2306-3513-2011-1-5-16 · Cited by 6
Etiologies of Cushing’s Syndrome
Newell-Price, J. D. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_2 · Cited by 6
Ziaja, J., Cholewa, K., Mazurek, U. M., & Cierpka, L. (2008) · PubMed · Cited by 6
Metabolic and cardiovascular impact of non-functioning adrenal adenomas: A clinical dilemma
Yener, S. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.02.005 · Cited by 6
Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?
Bahadır, Ç. T., Ecemiş, G. C., & Atmaca, H. N. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0869-1 · Cited by 5
Impact of Female Sex and Mild Cortisol Secretion on Coagulation Profile in Adrenal Incidentalomas
Bonaventura, I., Minnetti, M., Ferrari, D., Hasenmajer, V., Tomaselli, A., Alcubierre, D. D., Lenzi, A., Pofi, R., & Isidori, A. M. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae215 · Cited by 5
Yılmaz, N., Tazegül, G., Sarı, R., Avşar, E., Altunbaş, H., & Balcı, M. K. (2021) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2021.479 · Cited by 5
Doença de cushing subclínica: relato de três casos e revisão da literatura
Silva, B. C. C., Baruqui, A. M., Barbosa, V. E., Pena, G. P., Campos, M. H. D. F., Ramos, A. V., & Dias, E. P. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000400018 · Cited by 5
Screening Tests for Hypercortisolism in Patients With Adrenal Incidentaloma
Ferreira, L., Oliveira, J. C., & Palma, I. (2018) · Journal of Endocrinology and Metabolism · doi:10.14740/jem510w · Cited by 5
Ojeda, C. M., Santos, V. G. D., Álvaro, J. L., Ruz‐Caracuel, I., Pian, H. G., Dehesa, A. S., Revilla, F. J. B., & Castro, M. A. (2023) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.09.002 · Cited by 4
Ojeda, C. M., Santos, V. G. D., Álvaro, J. L., Ruz‐Caracuel, I., Pian, H. G., Dehesa, A. S., Revilla, F. J. B., & Castro, M. A. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.11.003 · Cited by 4
Wasmuth, A., van de Loo, I., Domberg, J., & Harbeck, B. (2025) · Endocrine · doi:10.1007/s12020-025-04192-0 · Cited by 4
Tzanela, M., Zianni, D., Stylianidou, C., Karavitaki, N., Tsagarakis, S., & Thalassinos, N. C. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02266.x · Cited by 4
The Cardiovascular Risk in Cushing’s Syndrome
Dobrescu, M., Păun, D. L., Grigorie, D., Ghemigian, A. M., & Poiană, C. (2019) · Internal Medicine · doi:10.2478/inmed-2019-0058 · Cited by 4
Babińska, A., Kmieć, P., & Sworczak, K. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.93486 · Cited by 4
BENGOA-ROJANO, N., Fernández-Argüeso, M., Botella-Carretero, J. I., Corrales, E. P., & Castro, M. A. (2022) · Revista Clínica Española · doi:10.1016/j.rce.2022.01.003 · Cited by 4
Conduite à tenir face à un incidentalome surrénalien associé à une hypertension artérielle
Mathonnet, M. (2005) · Annales de Chirurgie · doi:10.1016/j.anchir.2005.03.003 · Cited by 4
Síndrome de Cushing subclínica em populações de risco
Caetano, M. S. S., Vilar, L., & Kater, C. E. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800003 · Cited by 4
Rubini, G., Altini, C., Iuele, F., Nappi, A. G., Sardaro, A., Sablone, S., Ferrari, C., & Introna, F. (2019) · PubMed · Cited by 4
The Role of Inositols in Endocrine and Neuroendocrine Tumors
Mormando, M., Puliani, G., Bianchini, M., Lauretta, R., & Appetecchia, M. (2024) · Biomolecules · doi:10.3390/biom14081004 · Cited by 3
Lifestyle and Anthropometric Parameters in Patients with Nonfunctional Adrenal Incidentalomas
Dagdemir, A. N., & Akalın, A. (2023) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2023.25 · Cited by 3
Severe Obesity Associated With Pituitary Corticotroph Hyperplasia and Neoplasia
Lochner, R. H., Delfin, L., Nezami, B. G., Cohen, M. L., Asa, S. L., Burguera, B. G., & Couce, M. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.03.274 · Cited by 3
Actualités du syndrome de Cushing d’origine surrénalienne
Haissaguerre, M., & Tabarin, A. (2014) · Annales d Endocrinologie · doi:10.1016/s0003-4266(14)70025-3 · Cited by 3
Clinically Inapparent Adrenal Mass (Incidentaloma or Adrenaloma)
Linos, D. A. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_24 · Cited by 3
Tabarin, A., Collet, D., Galli, F. S., Maire, J.-P., & Loiseau, H. (2006) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(06)40170-0 · Cited by 3
[Secondary forms of diabetes mellitus associated with endocrine diseases].
Borges-Martins, L., Betea, D., Daly, A., & Beckers, A. M. (2005) · PubMed · Cited by 3
Fang, Y. (2011) · International Journal of Urology · doi:10.1111/j.1442-2042.2011.02843.x · Cited by 3
Erdogan, H. B., Gül, K., Şahutoğlu, T., & Erdoğan, Ş. V. (2025) · Endocrine Connections · doi:10.1530/ec-25-0259 · Cited by 2
Akkuş, G., Aksoydan, Ü. P., Odabaş, F., Binokay, H., Sert, M., & Tetıker, T. (2025) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/0115734056347340241009102228 · Cited by 2
Costa, J. M., Rebelo, J. F. D., Perozo, A. F. D. F., Junqueira, F. D., de Almeida, A. B. A. B. S., Milaresco, J. S., Souza, M. D. S., Moraes, A. B., Dantas, J. R., & Neto, L. V. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1659353 · Cited by 2
The Microbiome Epoch: Cracking the Cardiovascular-Neurodegenerative Disorder Code
Parolini, C., & Amedei, A. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl47174 · Cited by 2
Kaštelan, D., Dušek, T., Aganović, I., Štern-Padovan, R., Kuzmanić, D., Kaštelan, Ž., Knežević, N., Crnčević-Orlić, Ž., Kraljević, I., Džubur, F., et al. (2010) · Liječnički vjesnik · Cited by 2
The Prevalence of Incidental Adrenal Mass Found Using Diagnostic Imaging Techniques
Şen, H., Aşık, M., Uysal, F., Kızıldağ, B., Binnetoğlu, E., Güneş, F., Erbağ, G., & Ükinç, K. (2013) · Endocrinology research and practice. · doi:10.4274/tjem.2430 · Cited by 2
Relevance and perspective concept of investigation of subclinical Cushing syndrome.
Kuznetsov, N. S., Latkina, N. V., & Kaminarskaya, Y. A. (2016) · Endocrine Surgery · doi:10.14341/serg2016113-22 · Cited by 2
Features of metabolic syndrome in patients with adrenal incidentalomas
Kiszczak-Bochyńska, E., Oszywa-Chabros, A., Kurowska, M., Malicka, J. E., Dudzińska, M., & Tarach, J. S. (2014) · Family Medicine & Primary Care Review · Cited by 2
Case Report: Differentiating Obesity from Subclinical Cushing ’s Syndrome
(2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s11-003 · Cited by 2
Inoue, M., Ide, H., Kurihara, K., Koseki, T., Yu, J., China, T., Saito, K., Isotani, S., Muto, S., & Horie, S. (2012) · Korean journal of urology · doi:10.4111/kju.2012.53.6.414 · Cited by 2
Can non-functional adrenal incidentaloma be ranked among cardiovascular risk factors?
Yağız, B., Akalın, A., Yorulmaz, G., Macunluoğlu, A. C., & YAĞIZ, O. (2022) · The European Research Journal · doi:10.18621/eurj.872835 · Cited by 2
ACTH-dependent Cushing's syndrome
Fernandes, S., Varlamov, E. V., & Fleseriu, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00011-x · Cited by 2
Trandafir, A.-I., Stanciu, M., Albu, S. E., Stoian, V. R., CIOFU, I., Persu, C., Nistor, C., & Carşote, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134244 · Cited by 2
Langer, P., Waldmann, J., & Rothmund, Μ. (2007) · Der Chirurg · doi:10.1007/s00104-007-1365-x · Cited by 2
Obesity, Diabetes, and Hypertension
Tan, A. S., Brietzke, S., Gardner, D. W., & Sowers, J. R. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_10 · Cited by 2
Frequency of Nodular Goiter in Patients with Non-Functional Adrenal Incidentaloma
Can, M., Karaköse, M., Kocabaş, M., BURGUCU, H. Ç., Karakurt, F., Kulaksızoğlu, M., & Çordan, İ. (2020) · Endocrinology research and practice. · doi:10.25179/tjem.2020-75427 · Cited by 1
The Hormonal Status Comparison of Unilateral and Bilateral Adrenal Adenomas: Are They the Same?
Özbaş, B., Canpolat, A. G., Özbaş, C., Çorapçıoğlu, D., & Şahin, M. (2023) · European Journal of Therapeutics · doi:10.58600/eurjther665 · Cited by 1
Alberti, C. (2009) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche) · Cited by 1
Diagnosis and Clinical Pictures
Parenti, G., & Mannelli, M. (2012) · Springer eBooks · doi:10.1007/978-88-470-2586-8_4 · Cited by 1
Kuznetsov, N. S., & Tihonova, O. V. (2015) · Endocrine Surgery · doi:10.14341/serg2015122-34 · Cited by 1
Management of adrenal incidentaloma
Kaštelan, D. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.75 · Cited by 1
Di, D. G., Vicennati, V., Rinaldi, E., Morselli‐Labate, A. M., Giampalma, E., Mosconi, C., Pagotto, U., & Pasquali, R. (2012) · 15th International & 14th European Congress of Endocrinology · Cited by 1
Diagnostic Approach to Incidentaloma
Willenberg, H. S., & Bornstein, S. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_5 · Cited by 1
Nam, K.-J., Kim, Y. J., Lee, S. Y., Lee, J. G., Cho, Y. H., Lee, Y.-H., Choi, E., Tak, Y. J., Yi, D., Park, S., et al. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.4.289 · Cited by 1
Using Continuous Glucose Monitoring for Steroid-Induced Diabetes
Lu, J., & Jia, W. (2018) · Springer eBooks · doi:10.1007/978-981-10-7074-7_17 · Cited by 1
Lirov, R., & Gauger, P. G. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_26 · Cited by 1
Measurement of midnight ACTH levels is useful for the evaluation of midnight cortisol levels
Baba, R., Oki, K., Kobuke, K., Itcho, K., Okubo, H., Ohno, H., Yoneda, M., & Hattori, N. (2018) · Steroids · doi:10.1016/j.steroids.2018.10.011 · Cited by 1
Особенности клинического течения случайно выявленных образований надпочечников
Алимухамедова, Г. А. (2014) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.2.58.2014.76474 · Cited by 1
Bancos, I., Terzolo, M., & Arlt, W. (2022) · doi:10.1093/med/9780198870197.003.0095 · Cited by 1
Self-citationCandemir, B., Kisip, K., Akın, Ş., Sanal, H. T., Taşar, M., Altunkaynak, B., & Gülçelik, N. E. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111099 · Cited by 1
Spyroglou, A., Konstantakou, P., Minnetti, M., Altieri, B., Nowak, E., Papalexis, P., Angelousi, A. G., Vasiliadi, D., Kimpel, O., Macut, D., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04369-7 · Cited by 1
Metadata
- Authors
- Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., & Angeli, A.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo (IT)
- Corresponding author
- Terzolo, Massimo
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-03
- Volume
- 87
- Issue
- 3
- Pages
- 998-1003
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2109181100
- Cited by
- 322
- References
- 44
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 3 · 2023: 16 · 2022: 9 · 2021: 11 · 2020: 11 · 2019: 9 · 2018: 16 · 2017: 10 · 2016: 7 · 2015: 18 · 2014: 15 · 2013: 16 · 2012: 20
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal incidentaloma, subclinical Cushing's syndrome, metabolic syndrome, adrenal adenoma, impaired glucose tolerance, diabetes mellitus, hypertension, hypothalamic-pituitary-adrenal axis, cortisol excess, oral glucose tolerance test, body mass index, lipid profile, insulin resistance, obesity-related hypertension, obesity-related diabetes
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adult, Aged, Blood Pressure, Cushing Syndrome, Female, Humans, Insulin, Male, Middle Aged, Reference Values, Body Mass Index, Case-Control Studies, Glucose Intolerance, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.